[Antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: 2022: Guidelines from the supportive care committee of the French Society of Childhood Cancer (SFCE)].

{"article_title":"[Antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: 2022: Guidelines from the supportive care committee of the French Society of Childhood Cancer (SFCE)].","author":"Thouvenin-Doulet S, Mouffak S, Bertrand A, Cardine AM, Letort-Bertrand M, Levy D, Wiart-Monger V, Lervat C, Poir\u00e9e M","journal_title":"Bulletin du cancer","issn":"1769-6917","isbn":"","publication_date":"2022-11-01","volume":"109","issue":"11","first_page":"1144","page_count":"","accession_number":"36220696","doi":"10.1016\/j.bulcan.2022.08.003","publisher":"Elsevier","doctype":"English Abstract","subjects":"Antiemetics adverse effects; Neoplasms drug therapy; Antineoplastic Agents adverse effects; Hematology; Adult; Child; Humans; Nausea chemically induced; Nausea prevention & control; Vomiting chemically induced; Vomiting prevention & control","interest_area":["Oncology"," Pediatric Medicine"],"abstract":"Nausea and vomiting induced by cancer treatment (CINV) remain one of the most common and feared side effects in children despite the use of new drugs to prevent them. The existing recommendations for the prophylaxis and treatment of CINV are based on adult patients in Anglo-Saxon societies. Based on a recent review of the literature, we focused on specific pediatric issues in order to offer recommendations validated by the supportive care committee of the French society for childhood cancer. Copyright \u00a9 2022 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=36220696","isPdfLink":false,"isSAML":false,"an":"36220696","number_other":"","type_pub":"","issn_electronic":"1769-6917","languages":"French","language":"fre","date_entry":"Date Created: 20221011 Date Completed: 20221025 Latest Revision: 20231129","date_update":"20240105","titleSource":"Bulletin du cancer [Bull Cancer] 2022 Nov; Vol. 109 (11), pp. 1144-1153. Date of Electronic Publication: 2022 Oct 08.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-11-01","description":"Nausea and vomiting induced by cancer treatment (CINV) remain one of the most common and feared side effects in children despite the use of new drugs to prevent them. The existing recommendations for the prophylaxis and treatment of CINV are based on adult patients in Anglo-Saxon societies. Based on a recent review of the literature, we focused on specific pediatric issues in order to offer recommendations validated by the supportive care committee of the French society for childhood cancer.<br \/> (Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=36220696&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Thouvenin-Doulet S, Mouffak S, Bertrand A, Cardine AM, Letort-Bertrand M, Levy D, Wiart-Monger V, Lervat C, Poir\u00e9e M"}